Targeting histone deacetylases in pancreatic ductal adenocarcinoma. - Wikidata - awgldk - TriplyDB

Targeting histone deacetylases in pancreatic ductal adenocarcinoma.

Targeting histone deacetylases in pancreatic ductal adenocarcinoma.

http://www.wikidata.org/entity/Q37310587

about

Novel therapeutic targets for pancreatic cancer Ron knockdown and Ron monoclonal antibody IMC-RON8 sensitize pancreatic cancer to histone deacetylase inhibitors (HDACi)Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells.Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer.PI3K/mTOR dual inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A synergistically exert anti-tumor activity in breast cancer.Acetylation as a transcriptional control mechanism-HDACs and HATs in pancreatic ductal adenocarcinoma.Insights into the epigenetic mechanisms controlling pancreatic carcinogenesis.STAT5 acetylation: Mechanisms and consequences for immunological control and leukemogenesis.Generation and Assessment of Fusions Between HDACi and TKi.Histone deacetylase class-I inhibition promotes epithelial gene expression in pancreatic cancer cells in a BRD4- and MYC-dependent manner.Thymoquinone Promotes Pancreatic Cancer Cell Death and Reduction of Tumor Size through Combined Inhibition of Histone Deacetylation and Induction of Histone Acetylation.Inhibition of cancer migration and invasion by knocking down delta-5-desaturase in COX-2 overexpressed cancer cells Investigational histone deacetylase inhibitors for treating pancreatic adenocarcinoma.

P2860

Q24564267-9075C47C-116A-4295-8575-1A5858B6BD03 Q28534954-59207B0E-CDE8-48CA-A778-279DA9A30EC6 Q33801377-78826F22-4F17-46A1-BAB5-465A0C74D6CF Q33842416-D1277DDE-2D3B-407A-9E06-420FDCCDC44D Q37030911-CBF4BBF3-2933-4327-8B9F-66C31D0457E0 Q37707021-44EFAB24-5623-452F-8A6E-5967C038DAB7 Q37832684-1C61963F-D4D8-4C81-A21F-F3DF69725952 Q38052795-0AC097CB-6870-4BB6-880F-C07764FBA492 Q38177821-36917BDD-F820-4807-9A22-FE54CA28FE8F Q38739584-D57EE3FD-0460-4144-9E0A-D1C49B1EDE17 Q40951274-622B50DC-2A8D-4ACC-9B66-A716354DD052 Q40973109-D8DBB94F-0A04-4481-B0F0-76AC41100A6F Q42199704-0A1B12C6-036B-4BDF-BD57-B38507801450 Q53768454-7692DE5C-418D-4E23-B87A-B67278C8D9E8

P2860

Targeting histone deacetylases in pancreatic ductal adenocarcinoma.

http://www.wikidata.org/entity/Q37310587

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Targeting histone deacetylases in pancreatic ductal adenocarcinoma.

@en

Targeting histone deacetylases in pancreatic ductal adenocarcinoma.

@nl

type

label

Targeting histone deacetylases in pancreatic ductal adenocarcinoma.

@en

Targeting histone deacetylases in pancreatic ductal adenocarcinoma.

@nl

prefLabel

Targeting histone deacetylases in pancreatic ductal adenocarcinoma.

@en

Targeting histone deacetylases in pancreatic ductal adenocarcinoma.

@nl

P1433

Q37310587-47217E96-0FBA-4555-B638-FBC9D3C33988

P1476

Q37310587-1FE2CBBF-CCAC-49F5-90D8-0C2A185CFDAE

P2093

Q37310587-25F96478-A464-41A4-BE79-7FF207024678

Q37310587-33CC9513-1C72-456C-9674-139EC4C3811C

Q37310587-4366BA07-2C2F-495D-AF47-DB4128271D6F

Q37310587-687C483C-3EA8-4183-9818-3E5F333C183A

Q37310587-6F6C2E74-0DD6-44CC-8BB6-FAC28B5CE8C8

Q37310587-C4FF6D4A-09B3-4CE8-B87A-6C67D551AFC8

P2860

Q37310587-028AE539-F162-464B-94A1-20EB07291504

Q37310587-04C7C186-347C-4ECB-B5B4-7C6A3BF165A9

Q37310587-05061D6A-90D0-4855-A98D-5CCA4F98E08A

Q37310587-084CE8A6-B384-4798-8842-AB22CDA58B1A

Q37310587-0A0EB1B7-714B-4E72-BA99-4F3115DC2442

Q37310587-0E9B83B6-8B1E-47E4-B42E-5BB58DF64BBA

Q37310587-1FAC7D61-4F51-4829-899C-7032E59656E5

Q37310587-22A5806C-B56D-4C56-BB27-E56A71D9B55D

Q37310587-2724E5DC-CE65-4114-807E-30F0EECCD8EF

Q37310587-2DAF658B-A375-4D89-8209-E6D55720F691

P304

Q37310587-3492A31A-772F-4A01-A44A-362165C87369

P31

Q37310587-0E57DEF4-633F-47C5-9074-DF88375D750D

Q37310587-726C9E2B-D43B-41E4-B6F0-C22C6A6C75AD

P356

Q37310587-45564EEE-25DD-45F5-A4DE-91CEDBABE623

P433

Q37310587-26E1ED5B-DCCD-4C18-A331-080E1D3D00A9

P478

Q37310587-396F85EA-5CB5-4F29-83C5-FD5AFB0EB0FD

P577

Q37310587-143D11AA-D716-48DE-9FE5-F41EF4E14A91

Q37310587-338FFB99-5FB2-4040-BCFE-1EFF081112F8

P5875

Q37310587-5EE33CA2-02CC-470E-A89D-83007561BEC0

P698

Q37310587-9842B4E0-03C9-4849-B300-E00A859251F7

P921

Q37310587-474E42F1-C276-4152-868F-C375B9959AA0

Q37310587-4BBBEE80-8B39-4B47-94B5-71B3DF1E9A2F

Q37310587-651CAAE3-7041-4E15-96A5-56AE9449F82B

Q37310587-6B4A0A50-D645-44EB-A515-805D9160AEC5

Q37310587-89F5AB97-C608-497F-8878-29326AFE38AC

Q37310587-B4C97F27-5510-44A1-BC85-DE290E6215C2

P932

Q37310587-E111C632-782A-4364-A321-86782F5E831A

P356

J.1582-4934.2009.00974.X

P1433

Journal of Cellular and Molecular Medicine

P1476

Targeting histone deacetylases in pancreatic ductal adenocarcinoma.

@en

P2093

Dieter Saur

http://www.w3.org/2001/XMLSchema#string

Günter Schneider

http://www.w3.org/2001/XMLSchema#string

Oliver H Krämer

http://www.w3.org/2001/XMLSchema#string

Petra Fritsche

http://www.w3.org/2001/XMLSchema#string

Roland M Schmid

http://www.w3.org/2001/XMLSchema#string

Susanne Schüler

http://www.w3.org/2001/XMLSchema#string

P2860

Negative control of p53 by Sir2alpha promotes cell survival under stress

HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism

The many roles of histone deacetylases in development and physiology: implications for disease and therapy

Histone deacetylase inhibitors: Potential in cancer therapy

Histone deacetylases and cancer

Acetylation of non-histone proteins modulates cellular signalling at multiple levels

Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication

Complex networks orchestrate epithelial-mesenchymal transitions

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

Anticancer activities of histone deacetylase inhibitors

P304

1255-1263

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1582-4934.2009.00974.X

http://www.w3.org/2001/XMLSchema#string

P433

6A

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40023410

http://www.w3.org/2001/XMLSchema#string

P698

19929947

http://www.w3.org/2001/XMLSchema#string

P921

pancreatic cancer

mechanism of action

pancreatic neoplasm

pancreatic ductal adenocarcinoma

P932

3828843

http://www.w3.org/2001/XMLSchema#string